Treatment for Myeloma

ASH 2017 Daily Wrap: Day Three

In day three of Patient Power’s daily wrap up from the 2017 ASH meeting in Atlanta, Andrew and Esther Schorr are joined by a panel of experts.


ASH 2017 Myeloma Roundtable: Game-Changing Treatment Tools in Myeloma

A roundtable of esteemed myeloma experts including Dr. Carol Ann Huff, Dr. Sagar Lonial and Dr. Suzanne Lentzsch weigh in on the breaking news out of ASH 2017 for myeloma patients.


ASH 2017 Daily Wrap: Day Two

In day two of Patient Power’s daily wrap-up from ASH 2017, Andrew and Esther Schorr are joined by Dr. Mike Thompson, Dr. Mohit Trikha and patient advocate Cynthia Chmielewski.


ASH 2017 Daily Wrap: Day One

Patient Power founders Andrew and Esther Schorr are joined by MPN expert Dr. Naveen Pemmaraju, as they discuss research news from the 2017 ASH meeting.


Can Daily Exercise Impact Transplant Candidacy for Myeloma Patients?

A 25-year myeloma survivor, Jim Bond, shares his experience with the influence exercise has on transplant candidacy.


A Look at Monoclonal Antibodies: Sniffing Out Myeloma, Boosting Immunity

Dr. Gareth Morgan of The UAMS Myeloma Institute explains what monoclonal antibodies can do for myeloma patients.


Can Genetic Profiles Change During Cancer Treatment?

Dr. Brian Walker and Dr. Frits van Rhee discuss the possibility of genetic mutations occurring and how it can affect treatment. Watch now to find out more.


Can Genetic Profiling Identify Higher Risk Myeloma?

What can a genetic profile reveal about your myeloma condition? Join us to hear from our expert panel how the information from this diagnostic test can lead to better treatment.


Can Genetic Profiling in Myeloma Determine Treatment Strategies?

Dr. Faith Davies and Dr. Brian Walker share how tests revealing gene expression profile can improve care for myeloma patients.


Showing 9 of 274 programs

Page last updated on October 19, 2015